Point-of-Care Testing (POCT) Market is Expected to Reach US$ 35 - Erie News Now | WICU & WSEE in Erie, PA

Point-of-Care Testing (POCT) Market is Expected to Reach US$ 35 Billion By 2022

Posted:

New York, September 25, 2017 /Financeswire/: Market Research Engine has published a new report titled as “Point-of-Care Testing (POCT) Market By Product Type (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing); By End-User Type (Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals) and by regional analysis – global forecast by 2016 – 2022”

The Global Point-of-Care Testing (POCT) Market is segmented on the lines of its technology, treatment, application and regional. Based on product type segmentation it covers Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing and Others. Based on End user it covers Clinics, Home, Laboratories, Assisted living healthcare facilities and Hospitals. Global Point-of-Care Testing (POCT) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Global Point-of-Care Testing (POCT) Market is expected to exceed more than US$ 35.2 Billion by 2022 at a CAGR of 9% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/point-of-care-testing-market

The major driving factors of Global Point-of-Care Testing (POCT) Market are as follows:

  • High Prevalence of Infectious Diseases in Developing Countries
  • Increasing Incidence of life style Diseases
  • personal Investments and risk capital Activities
  • Technological Advancements and New Product Launches
  • Growing range of restrictive Approvals for Novel immunochemical assay Techniques
  • Shortage of complete Laboratory Technicians Increasing Preference of POC Testing
  • Rising range of Clia-Waived POC Tests

The restraining factors of Global Point-of-Care Testing (POCT) Market are as follows:

  • Product recollects
  • Pricing Pressures as a result of compensation Cuts and Budget Constraints Hampering Profits
  • Demanding and time-consuming restrictive Policies

This report provides:

1) An overview of the global market for Global Point-of-Care Testing (POCT) Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Point-of-Care Testing (POCT) Market.

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report Scope:

The scope of the report includes a detailed study of Global Point-of-Care Testing (POCT) Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Acrongenomics, Inc., Siemens AG, Abbott Laboratories, Inc. Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc. AccuBioTech Co., Ltd., ACON Laboratories, Inc., bioMrieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc. Alpha Scientific, Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Point-of-Care Testing (POCT) Market has been segmented as below:

By Product Type:

  • Glucose Monitoring
  • Cardiac Markers
  • Infectious Diseases Testing
  • Cholesterol Testing
  • Coagulation Monitoring
  • Pregnancy And Fertility Testing
  • Hematology Testing
  • Blood Gas Testing
  • Others

By End-User Type:

  • Clinics
  • Home
  • Laboratories
  • Assisted living healthcare facilities
  • Hospitals

By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

 

Source: http://www.financeswire.com/point-of-care-testing-poct-market-is-expected-to-reach-us-35-billion-by-2022

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com